Dr. Todd Daniel Rozen, MD

Dr. Rozen practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Rozen's NPI, 1902999006, was assigned on October 2, 2006. Dr. Rozen graduated from SUNY Downstate Health Sciences University in 1993. Dr. Rozen holds Florida license ME123340.

Dr. Rozen's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Rozen's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rozen practices. Vendor and product names are available with a free account.

Neurology is Dr. Rozen's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Rozen is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Rozen's licenses on file in 5 states: Florida, Pennsylvania, Michigan, Ohio and Minnesota.

Dmand AI lists acute mini-stroke (TIA), lower back pain, migraine and chronic headache and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Rozen treats.

CMS data shows 124 Medicare services from Dr. Rozen across 3 procedure codes in 2024, all of them office visits, for 142 Medicare patients. Medicare paid $10,309 for them. Every service was in an office.

CMS counts 142 Medicare patients who saw Dr. Rozen in 2024. The largest group is 65 to 74, with 69 patients. 68% of them have high cholesterol, and 63% have arthritis. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rozen's median patient age at 53, with 71% women.

In 2024, Dr. Rozen wrote 263 Medicare Part D claims for 68 patients. 79% of them were for generic drugs. CMS names the drug for 123 of them, across 8 drugs with 11 or more claims each, at $12,722 in total drug cost. In 2023, CMS named 93 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Rozen for performance year 2024, reported as part of a group.

Dmand AI links 97 papers to Dr. Rozen, published from 2008 to 2024. 2013 was the busiest year, with 6. The most frequent topics are Migraine Disorders, Headache Disorders and Headache. Dr. Rozen has published most often in Headache. Dr. Rozen's most frequent co-authors are Zlatko Devcic, MD, Young Mi Erben, MD and Thien Huynh, MD, MS.

Dmand AI links Dr. Rozen to 4 clinical trials. Conditions studied include Cluster Headache, Trigeminal Autonomic Cephalalgias and Migraine Disorders. Eli Lilly and Company sponsors the most, 2.

CMS Open Payments shows 12 general payments to Dr. Rozen from 2 drug and device companies from 2016 to 2019. Consulting fees make up the largest share, 79% of the total. Eli Lilly and Company paid the most, $7,346.

Dmand AI lists 1 award for Dr. Rozen, most recently CMS Stage 1 EHR in 2013.

Dr. Rozen graduated from SUNY Downstate Health Sciences University in 1993.

Dr. Rozen is in network with 11 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.